XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration

Key Points XLV offers a significantly lower expense ratio and a higher dividend yield compared to IBB. IBB has delivered higher one-year returns but carries substantially higher volatility and a deeper historical drawdown. XLV provides broad exposure to the S&P 500 healthcare sector, while IBB concentrates exclusively on the biotechnology industry. 10 stocks we like better than Select Sector SPDR Trust - State Street Health Care Select Sector SPDR ETF › Investors seeking healthcare exposure must choose between the stability of diversified pharmaceutical giants and the high-growth potential of specialized biotech firms.